Merck and Simcere Pharmaceutical announced on September 19 the official start of their JV operations. The deal was signed in July 2011 to form a JV (Merck 51%, Simcere49%) which...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)